Click Therapeutics
Click Therapeutics Leadership & Management
What People Are Saying About Click Therapeutics
-
Strategic Vision & Planning: Leadership consistently communicates a regulated, evidence-based “software as medicine” strategy that pairs prescription digital therapeutics with “Software‑Enhanced Drugs” in a partner‑first model. Concrete moves—FDA submissions/clearances, pharma collaborations, and a transition toward commercialization—are repeatedly tied to this plan.
-
Strong Execution: Regulatory milestones such as Rejoyn clearance and CT‑132 authorization, along with product launches, indicate follow‑through on stated objectives. Strategic financings and collaborations (e.g., Medidata/Dassault Systèmes and Boehringer Ingelheim) align resourcing with the operating model leadership describes.
-
Adaptability & Agility: A revised Boehringer Ingelheim agreement transferring CT‑155 commercialization to Click alongside rapid restructuring shows willingness to realign responsibilities and resources for the next phase. Public framing presents this as a natural transition from R&D to commercialization.
Click Therapeutics's Benefits
Hosts in-person all-hands meetings
Implements team-based strategic planning
Open office floor plan to encourage communication and collaboration
Uses an OKR operational model to clearly define goals and priorities
Utilizes an open door policy that encourages accessibility
